SC14D9C

0001193125-22-267663.txt : 20221024 0001193125-22-267663.hdr.sgml : 20221024 20221024172242 ACCESSION NUMBER: 0001193125-22-267663 CONFORMED SUBMISSION TYPE: SC14D9C PUBLIC DOCUMENT COUNT: 15 FILED AS OF DATE: 20221024 DATE AS OF CHANGE: 20221024 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001273636 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593553710 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC14D9C SEC ACT: 1934 Act SEC FILE NUMBER: 005-88071 FILM NUMBER: 221326608 BUSINESS ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: 386-462-2204 MAIL ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001273636 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593553710 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC14D9C BUSINESS ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: 386-462-2204 MAIL ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 SC14D9C 1 d384239dsc14d9c.htm SC14D9C SC14D9C

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14D-9

(Rule 14d-101)

SOLICITATION/RECOMMENDATION STATEMENT

PURSUANT TO SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934

Applied Genetic Technologies Corporation

(Name of Subject Company)

Applied Genetic Technologies Corporation

(Name of Person(s) Filing Statement)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

03820J 10 0

(CUSIP Number of Common Stock)

Susan B. Washer

President and Chief Executive Officer

Applied Genetic Technologies Corporation

14193 NW 119^th Terrace, Suite 10

Alachua, Florida 32615

(386) 462-2204

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of the Person(s) Filing Statement)

With copies to:

Stacie S. Aarestad

Ryan M. Rourke Reed

Foley Hoag LLP

155 Seaport Boulevard

Boston, MA 02110

(617) 832-1000

Hope D’Oyley-Gay

General Counsel

Applied Genetics Technologies Corporation

One Kendall Square, 1400W

Suite 14102

Cambridge, MA 02139

(617) 843-5728

☒	Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

This Schedule 14D-9 filing consists of the following documents relating to the proposed acquisition of Applied Genetics Technologies Corporation (the “Company”), a Delaware corporation, pursuant to the terms of an Agreement and Plan of Merger (the “Merger Agreement”), dated as of October 23, 2022, by and among Alliance Holdco Limited (“Parent”), a private limited company organized under the laws of England and Wales, Alliance Acquisition Sub, Inc. (the “Purchaser”), a Delaware corporation and a wholly-owned subsidiary of Parent, and the Company. Pursuant to the Merger Agreement, upon the terms and subject to the conditions thereof, the Purchaser will commence a tender offer (the “Offer”) for all of the Company’s outstanding shares of common stock (“Common Stock”) for: (1) $0.34 per share of Common Stock; and (2) one contingent value right (each a “CVR”) per share representing the right to receive potential milestone payments pursuant to and subject to the terms of the CVR Agreement. Upon completion of the Offer, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Purchaser will be merged (the “Merger”) with and into the Company, with the Company surviving as the wholly-owned subsidiary of Parent.

The information set forth under Items 1.01, 5.03, 8.01 and 9.01 of the Current Report on Form 8-K filed by the Company on October 24, 2022 (the “8-K”) (including all exhibits attached thereto) is incorporated herein by reference.

(i)

Company Press Release, dated October 23, 2022 (filed as Exhibit 99.1 to the 8-K and incorporated herein by reference)

(ii)

Transcript of joint investor conference call held on October 24, 2022 by the Company and Parent (filed as Exhibit 99.1 hereto)

(iii)

Internal Announcement and Frequently Asked Questions for Company Employees distributed to employees of the Company on October 24, 2022 (filed as Exhibit 99.2 hereto)

(iv)

Twitter Post linking to Company Press Release by the Company, dated October 24, 2022 (filed as Exhibit 99.3 hereto)

(v)

Twitter Post by the Company announcing Company and Parent joint investor conference call, dated October 24, 2022 (filed as Exhibit 99.4 hereto)

(vi)

Facebook Post linking to Company Press Release by the Company, dated October 24, 2022 (filed as Exhibit 99.5 hereto)

(vii)

Facebook Post by the Company announcing Company and Parent joint investor conference call, dated October 24, 2022 (filed as Exhibit 99.6 hereto)

(viii)

LinkedIn Post linking to Company Press Release by the Company, dated October 24, 2022 (filed as Exhibit 99.7 hereto)

(ix)

LinkedIn Post by the Company announcing Company and Parent joint investor conference call, dated October 24, 2022 (filed as Exhibit 99.8 hereto)

Forward-Looking Statements

Certain statements in this Schedule 14D-9 and in the exhibits attached hereto may constitute “forward-looking statements.” Such statements relate to a variety of matters, including but not limited to: the timing and anticipated completion of the Offer and the proposed Merger; and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the Company management’s current beliefs, expectations and assumptions and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise, except as required by law.

benefits of the transaction, future opportunities for the combined company and any other statements about future expectations, beliefs, goals, plans or prospects constitute forward-looking statements. Any statements that are not statements of historical fact (including statements containing “believes,” “anticipates,” “plans,” “expects,” “may,” “will,” “would,” “intends,” “estimates” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: the risk that the proposed transactions may not be completed in a timely manner, or at all; the failure to satisfy all of the closing conditions of the proposed transactions; the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement and the tender offer thereunder; the effect of the announcement or pendency of the proposed transactions on the Company’s business and operating results; the risk that the proposed transactions may disrupt the Company’s current plans and business operations; potential difficulties retaining employees as a result of the proposed transactions; risks related to the diverting of management’s attention from the Company’s ongoing business operations; the outcome of any legal proceedings that may be instituted against the Company related to the merger agreement or the tender offer thereunder; the Company’s product development and regulatory progress, including statements about the timing and outcomes from data expected in its Skyline and Vista trials and the type of data that may support registration and potential approval. Actual results could differ materially from those discussed in these forward-looking statements, due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process, the extent and duration of the impact of the COVID-19 pandemic, and other risk factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended June 30, 2022 filed with the SEC on September 27, 2022. Any forward-looking statements contained in this Schedule 14D-9 speak only as of the date hereof, and the Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Additional Information and Where to Find It

The tender offer for the outstanding shares of the Company referenced in this Solicitation/Recommendation Statement has not yet commenced. This Solicitation/Recommendation Statement is neither an offer to purchase nor a solicitation of an offer to sell any securities, nor is it a substitute for the tender offer materials that the Purchaser, the Parent and Syncona Portfolio Limited (“Syncona Portfolio”) will file with the Securities and Exchange Commission. At the time the tender offer is commenced, the Purchaser, the Parent and Syncona Portfolio will file with the SEC a Tender Offer Statement on Schedule TO, and, thereafter, the Company will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the Securities and Exchange Commission with respect to the tender offer. The Company’s stockholders are strongly advised to read the tender offer materials (including the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents that have yet to be filed) and the Solicitation/Recommendation Statement because they will contain important information that should be read carefully before any decision is made with respect to the tender offer. The Tender Offer Statement and the Solicitation/Recommendation Statement will be available for free at the SEC’s website at www.sec.gov. Free copies of these materials and other tender offer documents will be made available by the information agent for the tender offer.

In addition to the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, the Company files annual, quarterly and special reports, proxy statements and other information with the SEC. The Company’s filings with the SEC are available to the public from the website maintained by the SEC at www.sec.gov. Additional copies of the tender offer materials may be obtained for free by contacting Applied Genetic Technologies Corporation at 14196 NW 119th Terrace, Suite 10, Alachua, Florida, 32165, Attention: Chief Financial Officer.

EX-99.1 2 d384239dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

AGTC Conference Call

Script Operator

Good morning and welcome to the AGTC conference call. Today’s call is being recorded. Before we get started, I would like to remind everyone that during this conference call, AGTC may make forward-looking statements, including statements about the proposed transactions between subsidiaries of Syncona Limited and AGTC, the expected timeline for completing the transactions, future financial and operating results and benefits of the transaction, future opportunities for the combined company and any other statements about future expectations, beliefs, goals, plans or prospects constitute forward-looking statements. Any statements that are not statements of historical fact (including statements containing “believes,” “anticipates,” “plans,” “expects,” “may,” “will,” “would,” “intends,” “estimates” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: the risk that the proposed transactions may not be completed in a timely manner, or at all; the failure to satisfy all of the closing conditions of the proposed transactions; the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement and the tender offer thereunder; the effect of the announcement or pendency of the proposed transactions on AGTC’s business and operating results; the risk that the proposed transactions may disrupt AGTC’s current plans and business operations; potential difficulties retaining employees as a result of the proposed transactions; risks related to the diverting of management’s attention from AGTC’s ongoing business operations; the outcome of any legal proceedings that may be instituted against AGTC related to the merger agreement or the tender offer thereunder; the company’s product development and regulatory progress, including statements about the timing and outcomes from data expected in its Skyline and Vista trials and the type of data that may support registration and potential approval. Actual results could differ materially from those discussed in these forward-looking statements, due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process, the extent and duration of the impact of the COVID-19 pandemic, and other risks described in the “Risk Factors” section of AGTC’s most recently filed annual report on Form 10-K and other periodic reports filed with the SEC. AGTC undertakes no obligation to update any forward-looking statements after the date of this call.

On October 23, 2022, AGTC issued a press release announcing its entry into a definitive agreement for the acquisition, by tender offer, of AGTC by an indirect subsidiary of Syncona Limited. The tender offer, or the offer for the outstanding shares of the company referenced in the press release, has not yet commenced. This call is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell securities, nor is it a substitute for the tender offer materials that Syncona will file with the Securities and Exchange Commission, or the SEC, upon commencement of the offer.

At the time the offer is commenced, subsidiaries of Syncona will file a tender offer statement on Schedule TO, and thereafter, the company will file a solicitation or recommendation statement on Schedule 14D-9 with the SEC with respect to the offer. The tender offer materials, including an offer to purchase, a related letter of transmittal and certain other tender offer documents and the solicitation or recommendation statement on Schedule 14D-9 will contain important information. The company’s stockholders are urged to read these documents carefully when they become available as each may be amended or supplemented from time to time because they will contain important information that holders of the company’s securities should consider before making any decision regarding tendering their securities. Holders of shares can obtain these documents when they are filed and become available free of charge from the SEC’s website at www.sec.gov or on the company’s website at www.agtc.com.

For introductions and opening remarks, I’d like to turn the call over to Sue Washer, Chief Executive Officer of AGTC. Please go ahead.

Sue Washer

Good morning and thank you all for joining us. With me on today’s call is Jon Lieber, our Chief Financial Officer and Chris Hollowood, Chief Investment Officer of Syncona.

We are pleased to discuss today’s announcement of AGTC’s proposed acquisition by a newly established portfolio company of Syncona. for total transaction consideration of up to approximately $73.5 million. The decision to be acquired by Syncona was made following an extensive strategic process and is being recommended because we believe this acquisition represents an attractive offer for stockholders, with the potential to receive significant premium returns through future Contingent Value Rights, or CVRs, which we will review shortly.

As many of you are aware, in May of this year we reported positive interim 3-month data from the expansion phase of our XLRP Phase 1/2 clinical trial program, known as Skyline.

Throughout the development of our XLRP and achromatopsia candidates, we have regularly reviewed potential financing and strategic options with the Board to ensure that we were optimizing our potential to create value for stockholders and patients. In the months since the data were reported, the Board has continued to evaluate a variety of financing and partnership scenarios. Based on these ongoing discussions we successfully executed a public offering of AGTC common stock that raised approximately $10 million. However, we have ongoing needs for additional capital to support the continued development of our XLRP program and, despite the favorable interim 3-month Skyline data, raising additional funds in the current capital markets environment for biotechnology companies is not a viable option on the timeline in which our company requires financing. After careful analysis and deliberation,

the Board unanimously agreed that the offer by Syncona clearly delivers the best strategic option and value to our stockholders. We are pleased that Syncona shares our belief in the potential of our asset and that they are ideally placed to deliver the next phase of bringing this transformational therapy to patients. I will now pause and pass to Chris Hollowood, Syncona’s Chief Investment Officer to provide some background on Syncona.

Chris Hollowood, Syncona CIO:

Good morning all and thank you Sue for the introduction. I am pleased to be here to discuss today’s announcement and wanted to take the opportunity to provide some background on Syncona and why we’re here today. We are a leading healthcare investor based in the UK. We were founded in 2012 by the Wellcome Trust and have developed a strong track record in creating life science companies and building and scaling them through the clinic. At the heart of our vision is to deliver transformational treatments to patients in areas of high unmet need and we believe there is a significant opportunity here to support a product with high potential in reaching patients. Our team has extensive experience in the field of retinal diseases and gene therapy. For example, Nightstar and Gyroscope, previously in our portfolio, were sold to Biogen and Novartis respectively. We founded these companies and took them both through to pivotal and phase II studies, remaining significant owners over six years for each of them. More broadly across the field of gene therapy we have a further three gene therapy companies in our current portfolio and so have created five since our foundation. We have an extensive network across the retinal community and part of our success has been to leverage this in the management teams we build and clinical and academic centers we work with. We intend to bring all of this experience to bear here to ensure high quality execution.

We believe that the AGTC-501 XLRP product candidate has the potential to be a best-in-class product that could transform the lives of patients suffering with this devasting blinding condition and believe we have the domain expertise and track record to enable our new portfolio company to advance this product through to patients. After the closing, we intend to work with the management team to support them to deliver a clinical plan for AGTC-501, which if successful, we believe has the potential to provide value to AGTC stockholders through the CVR. I will now pass back to Sue to provide more background on the factors contributing to the Board’s recommendation of this acquisition.

Sue Washer, CEO:

Thank you Chris. There were multiple factors that contributed to the Board’s unanimous recommendation for this acquisition.

The first was the status of our finances. The Company has limited cash resources, which in the absence of a transaction would only support future operations through the end of the calendar year 2022. In the context of challenging biotechnology capital markets, the Board considered our current share price and recognised the limitations on our ability to raise public equity. In the event that we were not able to raise public equity, the Company would have no alternative but to pursue a bankruptcy case where there would likely be a lack of capital available for distribution to stockholders. The Company’s operations were clearly considered in the context of our finances with the Board taking into consideration the costs and risks of the Company’s current product development pipeline.

In addition, the Board considered the competitive nature of the biopharmaceutical industry, particularly for small cap biotechs such as AGTC, the current perception of ophthalmology gene therapy by public market investors, our financial resources relative to those of our competitors, the potential impact of government healthcare reform on the Company’s business, and other general risks and market conditions that could reduce the market price of AGTC’s shares.

The Board also recognised that there are several well-financed companies partnered with large pharmaceutical companies which are developing gene therapy products, even specifically to treat XLRP.

The possibility of exploring additional licensing and collaboration opportunities, the potential benefits, and risks of these alternatives to the Company and its stockholders and the timing and likelihood of effecting such alternatives considering our limited financial resources was also considered. The Board determined that none of the possible alternatives was reasonably likely to present superior opportunities in a reasonable time for us to create greater value for the Company’s stockholders and could result in significantly lower value for the stockholders.

Another important factor in the Board’s decision was the relationship of the Offer Price to the current and historical market prices of the Shares. The Offer Price to be paid in cash for each Share would provide stockholders with the opportunity to receive a significant premium over the current market price of the Shares in cash as well as provide the opportunity for potential future additional value through CVRs.

Certainty of value was also a key driver for the Board’s recommendation. The consideration to be received by the AGTC stockholders in the Offer and the Merger will have a portion received as upfront cash, which provides liquidity and certainty of value to our stockholders. Considering the various risks that we would face by remaining independent and pursuing capital raising and/or business development opportunities to support continued operations, the Board believed that this certainty of value was compelling compared to the expected long-term value creation potential of our business.

Finally, this acquisition provides an attractive opportunity to realize potential additional cash value in a contingent value right, or CVR. The Board considered the fact that, in addition to the cash to be paid at Closing, AGTC’s stockholders will receive one CVR per share held by them. The CVR provides the opportunity to realize up to $0.73 in additional cash value if four milestones are met in accordance with their terms. The Board considered the estimated probability of success and estimated timing for achieving each milestone in evaluating the transaction.

Importantly, this acquisition will enable the continued advancement of our XLRP clinical program by a company which has a track record in building portfolio companies to develop similar candidates. We remain confident that our XLRP candidate has best-in-class potential in a serious indication for which currently there are no therapies.

At this time, I will now turn the call to Jon who will review the financial details of the merger agreement. Jon?

Jon Lieber

Thank you, Sue.

Under the terms of the definitive agreement, the upfront cash consideration in the transaction will consist of $0.34 per share of AGTC common stock including common stock underlying restricted stock units and in-the-money stock options. AGTC equity holders would also be entitled to receive, for each share of AGTC common stock, one non-tradeable CVR. The holders of the CVRs would be entitled to receive payments of up to an additional $50.0 million in the aggregate upon the achievement of certain milestones.

Including the maximum CVR payment, AGTC stockholders will receive up to an aggregate of $73.5 million in cash. The total payment represents a premium of up to approximately 344% to the current share price and a premium of approximately 268% over the 30-day volume weighted average closing price per share of AGTC’s common stock.

The transaction, which has been unanimously approved by the members of the AGTC Board, is expected to close within 30 business days, subject to customary closing conditions, including AGTC’s stockholders tendering a majority of AGTC’s outstanding shares. The transaction is not subject to a financing condition.

AGTC’s Board of Directors unanimously recommends that AGTC stockholders tender their shares in the tender offer as the best alternative to the likely lack of cash available for distribution to stockholders in the event that the Company has no alternative but to pursue a bankruptcy case. Upon the successful completion of the tender offer, AGTC will merge with a newly established portfolio company of Syncona and any remaining shares of common stock of AGTC that were not tendered in the tender offer will be canceled and converted into the right to receive the same consideration payable in the tender offer.

I’ll now turn the call back over to Sue for concluding remarks.

Sue Washer

Thank you, Jon.

We are pleased to announce this transaction with Syncona, which has a strong passion and deep commitment to bringing treatment solutions to patients in desperate need as demonstrated by Chris today. The decision to accept this offer was not only in our belief that it is in the best interests of stockholders, but that Syncona will continue advancing our leading XLRP candidate and has the best chance of bringing to market a treatment that patients have sought for years.

Since our inception, AGTC has been committed to developing therapies for patients living with serious inherited retinal diseases. Realizing that commitment has not always been easy, but it has remained our guiding principle. I, and the rest of the AGTC leadership team, agree with the Board’s unanimous recommendation that this acquisition agreement is the best option for remaining true to this ideal.

AGTC’s Board of Directors unanimously recommends that AGTC stockholders tender their shares in the tender offer as the best alternative to the likely lack of cash available for distribution to stockholders in the event that the Company has no alternative but to pursue a bankruptcy case. The cash and CVR payments are a significant premium to our current share price, providing stockholders with an opportunity to benefit from the longer-term potential of our XLRP program and other assets. It also ensures that stockholders will receive a cash distribution.

We intend to provide additional information in the days and weeks ahead and look forward to sharing additional information with you as this transaction progresses.

Thank you for joining us on today’s call.

Operator

Thank you, ladies and gentlemen, that concludes our conference for today. Thank you for your participation. You may now disconnect.

Forward-Looking Statements

This communication contains forward-looking statements. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans”, “will be” and similar expressions. These forward-looking statements include, without limitation, statements related to the anticipated consummation of the acquisition of the Company and the timing and benefits thereof, the anticipated contingent value right payments, and other statements that are not historical facts. These forward-looking statements are based on the Company’s current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the parties’ ability to complete the transaction on the proposed terms and schedule; whether the tender offer conditions will be satisfied; whether sufficient stockholders of the Company tender their shares in the transaction; the outcome of legal proceedings that may be instituted against the Company and/or others relating to the transaction; the failure (or delay) to receive the required regulatory approvals relating to the transaction; the possibility that competing offers will be made; risks relating to product development and commercialization and demand for AGTC’s products (and, as such, uncertainty that the milestones for the contingent value right payments may not be achieved); and other risks related to Company’s business detailed from time-to-time under the caption “Risk Factors” and elsewhere in Company’s SEC filings and reports, including their respective Annual Reports on Form 10-K for the year ended June 30, 2022 and subsequent quarterly and current reports filed with the SEC. Company undertakes no duty or obligation to update any forward-looking statements contained in this report as a result of new information, future events or changes in their expectations, except as required by law.

Additional Information and Where to Find It

The Offer has not yet commenced, and this communication is neither a recommendation, nor an offer to purchase nor a solicitation of an offer to sell any shares of the common stock of the Company or any other securities. On the commencement date of the Offer, a tender offer statement on Schedule TO, including an offer to purchase, a letter of transmittal and related documents, will be filed with the SEC by subsidiaries of Syncona Limited, and a Solicitation / Recommendation Statement on Schedule 14D-9 will be filed with the SEC by the Company. The offer to purchase shares of Company common stock will only be made pursuant to the offer to purchase, the letter of transmittal and related documents filed as a part of the Schedule TO. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ BOTH THE TENDER OFFER STATEMENT AND THE SOLICITATION / RECOMMENDATION STATEMENT REGARDING THE OFFER, AS THEY MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT INVESTORS AND SECURITY HOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR COMMON STOCK, INCLUDING THE TERMS AND CONDITIONS OF THE TENDER OFFER. Investors and security holders may obtain a free copy of these statements (when available) and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to the Information Agent for the Offer, which will be named in the tender offer statement. Investors may also obtain, at no charge, the documents filed or furnished to the SEC by the Company under the “Investors” section of the Company’s website at www.AGTC.com.

EX-99.2 3 d384239dex992.htm EX-99.2 EX-99.2

Exhibit 99.2

Confidential

CONFIDENTIAL – FOR INTERNAL USE ONLY

Internal Announcement

Frequently Asked Questions for Applied Genetic Technologies Corporation Employees

1.	What was announced?

Syncona Limited (“Syncona”) and Applied Genetic Technologies Corporation (“AGTC”) announced a definitive agreement pursuant to which a newly established portfolio company of Syncona will acquire AGTC for $0.34 per share in cash, plus one “contingent value right” (a “CVR”) per share. A CVR is a right to receive possible future cash payments if certain conditions are satisfied. Here, a CVR will entitle the recipient to up to an additional $0.73 per share in cash, based upon achievement of certain milestones. The transaction is currently anticipated to close in four to six weeks, subject to the positive response of stockholders to the proposed acquisition, the tender of at least a majority of the outstanding shares of AGTC common stock and the satisfaction of other closing conditions.

2.	Who is Syncona and why did the Board approve the agreement to be acquired by Syncona?

Syncona’s purpose is to invest to extend and enhance human life. It does this by founding and building companies to deliver transformational treatments to patients in areas of high unmet need. Its strategy is to found, build and fund companies around exceptional science to create a diversified portfolio of 15-20 globally leading healthcare businesses for the benefit of all of its stakeholders. It focuses on developing treatments for patients by working in close partnership with world-class academic founders and management teams.

As a public company, it is our responsibility to regularly assess ways to maximize the value of our business. Over the last few months our Board of Directors has conducted an extensive review of our options and ultimately our Board of Directors determined that Syncona’s offer recognizes this value for the benefit of all our stakeholders: our stockholders, our employees and the patients who motivate our mission.

We see their commitment to developing transformative medicines and we also believe they have a strong values-driven culture similar to ours.

3.	What happens next?

In the next few days, a subsidiary of Syncona will commence a tender offer to acquire all outstanding shares of AGTC common stock and we will file a recommendation statement containing the recommendation of the AGTC Board of Directors that AGTC stockholders tender their shares in the tender offer. If a majority of the outstanding shares of AGTC common stock are tendered during the tender offer, and all other conditions to closing the transaction are met, Syncona will acquire all outstanding shares of AGTC common stock tendered in the tender offer, and thereafter the indirect subsidiary of Syncona making the tender offer will merge with and into AGTC, resulting in AGTC becoming a portfolio company of Syncona.

4.	What does this mean for AGTC?

AGTC will become a private company and will no longer be subject to the reporting requirements of the Securities and Exchange Commission (“SEC”) nor be traded on Nasdaq Global Market, among other things.

5.	Why make this deal now?

As a public company, it is our responsibility to regularly assess ways to maximize the value of our business. Over the last few months our Board of Directors has conducted an extensive review of our options and after careful consideration, our Board unanimously concluded that the proposed transaction is in the best interest of our stockholders. Please refer to our Schedule 14D-9, which will be publicly filed and will provide a detailed background of the Board’s process and decision making, when available.

6.	What will change because of this transaction?

In 4-6 weeks AGTC will be acquired by Syncona and will become a portfolio company of Syncona, and the business will make strategic determinations about AGTC’s programs. Between the signing and closing of the transaction, AGTC and Syncona will remain separate, independent companies, and so we do not plan any changes to AGTC’s organizational structure prior to closing that would affect your role and responsibilities.

7.	Will there be layoffs or a reorganization?

As with any merger, there could be impacts on programs, functions and people; and additional information will be provided after the transaction closes. AGTC and Syncona will continue to operate as separate, independent entities prior to the closing of the proposed transaction, and, until that time, it is business as usual for both companies. As part of the merger agreement AGTC has agreed to conduct business as usual during the pendency of the transaction.

8.	What changes will this have on my day-to-day activities?

Prior to the formal closing of the transaction in 4-6 weeks, your day-to-day activities will not change. We understand that you have many questions about your role moving forward after the transaction closes; however, it is important that we continue to focus on our current responsibilities. One of the great attractions for Syncona during negotiations were the skills and expertise of our employees.

9.	Will AGTC Senior Management remain the same?

As the deal has not yet closed, there are many details to work out and nothing is changing today. The executive team is committed to the successful integration of AGTC into Syncona post-closing. Prior to closing we will be meeting with the Syncona team members so they can become more familiar with our people and our programs. During the pre-closing period, our expectation is that there will be no significant changes to our organization. Following closing, it is possible that certain members of the executive team may choose not to remain with the Company as it transitions to a private entity. Employees will be informed of any important changes.

10.

Are there any immediate changes to the current trials, patient dosing or upcoming milestones?

No. This is an important time for AGTC and we must maintain our momentum on our programs. Importantly the XLRP program remains our top priority. We are very early on in the integration planning process and are still evaluating potential changes. For now, your role and responsibilities are not changing. We are committed to operating in the ordinary course until transaction closing. Please continue to push forward with your work. As usual, please work with your manager if you have questions. As we discuss projects with Syncona we will communicate any changes to employees. Prior to signing any contracts, committing any Company funds, or committing any material external resources, you should discuss these activities with your manager or a member of the executive team.

11.

What resources can we expect Syncona to add?

When taking into account the best interests of our stockholders, employees and the patients we hope to one day serve with our products, we believe that Syncona has expertise and resources available to bring the XLRP program through clinical development at a scale that would be challenging for us to accomplish on our own.

We see their commitment to developing our XLRP program and we also believe they have a strong expertise in gene therapy and ophthalmology.

12.

Will Syncona also acquire the manufacturing facility?

Our strategy with the manufacturing facility was to establish control over our costs, quality and timelines and Syncona supports the same objectives. But we always had a view that it would be necessary to find like-minded partners to help fund the underlying costs of maintaining a GMP capable facility. We will continue to pursue options that allow the business to operate the facility in the most efficient way possible.

13.

Will the name of the company change?

Yes. It is expected that the name of the company will change post-closing. However, Syncona has not yet determined a trade name for that entity.

14.

What is the significance of the company “going private”?

As noted above, if the transaction closes, AGTC will become a US private company and will no longer be subject to the reporting requirements of the Securities and Exchange Commission (“SEC”) nor be traded on Nasdaq Global Market, among other things.

15.

What happens to my AGTC stock/options/RSUs?

If the tender conditions are satisfied and the merger closes each share will entitle the holder to receive (i) $0.34 in cash, without interest, plus (ii) one CVR which shall represent the right to receive potential milestone payments pursuant to the CVR Agreement.

At the closing of the transaction, each outstanding restricted stock unit award (“RSU”) will be accelerated and become fully vested without any action on your part. Each RSU will then be cancelled and converted into the right to receive (i) a cash payment equal to the product of the total number of shares issuable under that RSU immediately prior to the closing multiplied by $0.34, and (ii) one CVR for each of those issuable shares.

Any payments you receive in respect of your RSUs will be subject to applicable tax withholdings.

All of our outstanding Options have a per share exercise price that is greater than $0.34 and, if not exercised prior to closing, will automatically terminate and be canceled without payment of any consideration to the holder thereof (and will also not be eligible to receive any CVRs).

16.

Will going private impact how my compensation is structured?

Your total cash compensation including all benefits will remain the same and will continue to be provided through Insperity.

17.

Can I sell shares before the close of the transaction?

Our trading window is currently closed, and, given current circumstances, we will not open the trading window.

18.

Is there anything I need to do now in preparation for the close of the transaction related to any shares I own? Do I need to register them anywhere?

Details concerning the transaction, including who is entitled to receive transaction consideration and how to obtain transaction consideration, will be provided in the tender offer documents to be filed by Syncona and AGTC in their respective public filings regarding the transaction.

19.

Are there any closing conditions? What are the risks that the deal won’t close?

The proposed transaction is subject to certain closing conditions, including that at least a majority of the outstanding shares of AGTC common stock are tendered and the satisfaction of other customary closing conditions. Syncona and AGTC will be filing materials with the SEC that will provide more information on the proposed transaction.

20.

What should I do if I am contacted by the media, the financial community, or other third parties about the transaction?

Should you be contacted, please refer media and financial inquiries to Hope D’Oyley-Gay, General Counsel.

21.

Who do I ask if I have other questions regarding the transaction?

Please direct all questions to Hope, Jon, Sue, or Stephen.

Forward-Looking Statements

Additional Information and Where to Find It

purchase, the letter of transmittal and related documents filed as a part of the Schedule TO. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ BOTH THE TENDER OFFER STATEMENT AND THE SOLICITATION / RECOMMENDATION STATEMENT REGARDING THE OFFER, AS THEY MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME, WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT INVESTORS AND SECURITY HOLDERS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR COMMON STOCK, INCLUDING THE TERMS AND CONDITIONS OF THE TENDER OFFER. Investors and security holders may obtain a free copy of these statements (when available) and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to the Information Agent for the Offer, which will be named in the tender offer statement. Investors may also obtain, at no charge, the documents filed or furnished to the SEC by the Company under the “Investors” section of the Company’s website at www.AGTC.com.

EX-99.3 4 d384239dex993.htm EX-99.3 EX-99.3

Exhibit 99.3

On October 24, 2022, Applied Genetics Technologies Corporation (the “Company”) made the following announcement via Twitter regarding the planned cash tender offer (the “Offer”) by Alliance Acquisition Sub, Inc. (the “Purchaser”), a Delaware Corporation and wholly-owned subsidiary of Alliance Holdco Limited (“Parent”), a private limited company organized under the laws of England and Wales, to acquire all of the issued and outstanding shares of common stock, par value $0.001 per share, of the Company, a Delaware corporation, to be commenced pursuant to the Agreement and Plan of Merger, dated as of October 23, 2022, by and among Purchase, Parent and the Company (the “Merger Agreement”).

LOGO

Forward-Looking Statements

Certain statements in this communication may constitute “forward-looking statements.” Such statements relate to a variety of matters, including but not limited to: the timing and anticipated completion of the Offer and the proposed Merger (as defined in the Merger Agreement); and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the Company management’s current beliefs, expectations and assumptions and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise, except as required by law.

Factors that could cause actual results to differ materially from the forward-looking statements contained herein include, but are not limited to, statements about the proposed transactions between Parent and the Company, the expected timeline for completing the transactions, future financial and operating results and benefits of the transaction, future opportunities for the combined company and any other statements about future expectations, beliefs, goals, plans or prospects constitute forward-looking statements. Any statements that are not statements of historical fact (including statements containing “believes,” “anticipates,” “plans,” “expects,” “may,” “will,” “would,” “intends,” “estimates” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: the risk that the proposed transactions may not be completed in a timely manner, or at all; the failure to satisfy all of the closing conditions of the proposed transactions; the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement and the tender offer thereunder; the effect of the announcement or pendency of the proposed transactions on the Company’s business and operating results; the risk that the proposed transactions may disrupt the Company’s current plans and business operations; potential difficulties retaining employees as a result of the proposed transactions; risks related to the diverting of management’s attention from the Company’s ongoing business operations; the outcome of any legal proceedings that may be instituted against the Company related to the merger agreement or the tender offer thereunder; the Company’s product development and regulatory progress, including statements about the timing and outcomes from data expected in its Skyline and Vista trials and the type of data that may support registration and potential approval. Actual results could differ materially from those discussed in these forward-looking statements, due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process, the extent and duration of the impact of the COVID-19 pandemic, and other risk factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended June 30, 2022 filed with the SEC on September 27, 2022, as amended. Any forward-looking statements contained in this Schedule 14D-9 speak only as of the date hereof, and the Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Additional Information and Where to Find It

The tender offer for the outstanding shares of the Company referenced in this communication has not yet commenced. This communication is neither an offer to purchase nor a solicitation of an offer to sell any securities, nor is it a substitute for the tender offer materials that the Purchaser, the Parent and Syncona Portfolio Limited (“Syncona Portfolio”) will file with the Securities and Exchange Commission. At the time the tender offer is commenced, the Purchaser, the Parent and Syncona Portfolio will file with the SEC a Tender Offer Statement on Schedule TO, and, thereafter, the Company will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the Securities and Exchange Commission with respect to the tender offer. The Company’s stockholders are strongly advised to read the tender offer materials (including the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents that have yet to be filed) and the Solicitation/Recommendation Statement because they will contain important information that should be read carefully before any decision is made with respect to the tender offer. The Tender Offer Statement and the Solicitation/Recommendation Statement will be available for free at the SEC’s website at www.sec.gov. Free copies of these materials and other tender offer documents will be made available by the information agent for the tender offer.

EX-99.4 5 d384239dex994.htm EX-99.4 EX-99.4

Exhibit 99.4

LOGO

Forward-Looking Statements

transactions may disrupt the Company’s current plans and business operations; potential difficulties retaining employees as a result of the proposed transactions; risks related to the diverting of management’s attention from the Company’s ongoing business operations; the outcome of any legal proceedings that may be instituted against the Company related to the merger agreement or the tender offer thereunder; the Company’s product development and regulatory progress, including statements about the timing and outcomes from data expected in its Skyline and Vista trials and the type of data that may support registration and potential approval. Actual results could differ materially from those discussed in these forward-looking statements, due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process, the extent and duration of the impact of the COVID-19 pandemic, and other risk factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended June 30, 2022 filed with the SEC on September 27, 2022, as amended. Any forward-looking statements contained in this Schedule 14D-9 speak only as of the date hereof, and the Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Additional Information and Where to Find It

EX-99.5 6 d384239dex995.htm EX-99.5 EX-99.5

Exhibit 99.5

On October 24, 2022, Applied Genetics Technologies Corporation (the “Company”) made the following announcement via Facebook regarding the planned cash tender offer (the “Offer”) by Alliance Acquisition Sub, Inc. (the “Purchaser”), a Delaware Corporation and wholly-owned subsidiary of Alliance Holdco Limited (“Parent”), a private limited company organized under the laws of England and Wales, to acquire all of the issued and outstanding shares of common stock, par value $0.001 per share, of the Company, a Delaware corporation, to be commenced pursuant to the Agreement and Plan of Merger, dated as of October 23, 2022, by and among Purchase, Parent and the Company (the “Merger Agreement”).

LOGO

Forward-Looking Statements

proposed transactions on the Company’s business and operating results; the risk that the proposed transactions may disrupt the Company’s current plans and business operations; potential difficulties retaining employees as a result of the proposed transactions; risks related to the diverting of management’s attention from the Company’s ongoing business operations; the outcome of any legal proceedings that may be instituted against the Company related to the merger agreement or the tender offer thereunder; the Company’s product development and regulatory progress, including statements about the timing and outcomes from data expected in its Skyline and Vista trials and the type of data that may support registration and potential approval. Actual results could differ materially from those discussed in these forward-looking statements, due to a number of important factors, including uncertainty inherent in the clinical development and regulatory process, the extent and duration of the impact of the COVID-19 pandemic, and other risk factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended June 30, 2022 filed with the SEC on September 27, 2022, as amended. Any forward-looking statements contained in this Schedule 14D-9 speak only as of the date hereof, and the Company specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Additional Information and Where to Find It

EX-99.6 7 d384239dex996.htm EX-99.6 EX-99.6

Exhibit 99.6

LOGO

Forward-Looking Statements

Additional Information and Where to Find It

EX-99.7 8 d384239dex997.htm EX-99.7 EX-99.7

Exhibit 99.7

On October 24, 2022, Applied Genetics Technologies Corporation (the “Company”) made the following announcement via LinkedIn regarding the planned cash tender offer (the “Offer”) by Alliance Acquisition Sub, Inc. (the “Purchaser”), a Delaware Corporation and wholly-owned subsidiary of Alliance Holdco Limited (“Parent”), a private limited company organized under the laws of England and Wales, to acquire all of the issued and outstanding shares of common stock, par value $0.001 per share, of the Company, a Delaware corporation, to be commenced pursuant to the Agreement and Plan of Merger, dated as of October 23, 2022, by and among Purchase, Parent and the Company (the “Merger Agreement”).

LOGO

Forward-Looking Statements

Additional Information and Where to Find It

EX-99.8 9 d384239dex998.htm EX-99.8 EX-99.8

Exhibit 99.8

LOGO

Forward-Looking Statements

Additional Information and Where to Find It

GRAPHIC 10 g384239g1024220832072.jpg GRAPHIC begin 644 g384239g1024220832072.jpg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end GRAPHIC 11 g384239g1024220922615.jpg GRAPHIC begin 644 g384239g1024220922615.jpg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g384239g1024221024545.jpg GRAPHIC begin 644 g384239g1024221024545.jpg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end GRAPHIC 13 g384239g1024221112002.jpg GRAPHIC begin 644 g384239g1024221112002.jpg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end GRAPHIC 14 g384239g1024221214903.jpg GRAPHIC begin 644 g384239g1024221214903.jpg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end GRAPHIC 15 g384239g1024221316550.jpg GRAPHIC begin 644 g384239g1024221316550.jpg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